In vitro experiments showed that EFNB2 promoted the viability of CRC cells via EPHB4, but not the other EPH receptors (EPHB1, EPHB2, EPHB3, EPHB6, and EPHA4) (Figs. 3B and S3A–S3F). This evidence concerns the gene EPHB3 and colorectal carcinoma.